Literature DB >> 32339215

Clinical Impact of Renin-angiotensin System Inhibitors on In-hospital Mortality of Patients With Hypertension Hospitalized for Coronavirus Disease 2019.

Sara Tedeschi1, Maddalena Giannella1, Michele Bartoletti1, Filippo Trapani1, Marina Tadolini1, Claudio Borghi2, Pierluigi Viale1.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 32339215      PMCID： PMC7197592          DOI： 10.1093/cid/ciaa492

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  22 in total

Review 1.  Heterogeneity and Risk of Bias in Studies Examining Risk Factors for Severe Illness and Death in COVID-19: A Systematic Review and Meta-Analysis.

Authors:  Abraham Degarege; Zaeema Naveed; Josiane Kabayundo; David Brett-Major
Journal:  Pathogens       Date:  2022-05-10

Review 2.  Renin-Angiotensin Aldosterone System Inhibitors and COVID-19: A Systematic Review and Meta-Analysis Revealing Critical Bias Across a Body of Observational Research.

Authors:  Jordan Loader; Frances C Taylor; Erik Lampa; Johan Sundström
Journal:  J Am Heart Assoc       Date:  2022-05-27       Impact factor: 6.106

3.  COVID-19: age, Interleukin-6, C-reactive protein, and lymphocytes as key clues from a multicentre retrospective study.

Authors:  Aurora Jurado; María C Martín; Cristina Abad-Molina; Antonio Orduña; Alba Martínez; Esther Ocaña; Oscar Yarce; Ana M Navas; Antonio Trujillo; Luis Fernández; Esther Vergara; Beatriz Rodríguez; Bibiana Quirant; Eva Martínez-Cáceres; Manuel Hernández; Janire Perurena-Prieto; Juana Gil; Sergi Cantenys; Gema González-Martínez; María T Martínez-Saavedra; Ricardo Rojo; Francisco M Marco; Sergio Mora; Jesús Ontañón; Marcos López-Hoyos; Gonzalo Ocejo-Vinyals; Josefa Melero; Marta Aguilar; Delia Almeida; Silvia Medina; María C Vegas; Yesenia Jiménez; Álvaro Prada; David Monzón; Francisco Boix; Vanesa Cunill; Juan Molina
Journal:  Immun Ageing       Date:  2020-08-14       Impact factor: 6.400

4.  Chronic use of renin-angiotensin-aldosterone system blockers and mortality in COVID-19: A multicenter prospective cohort and literature review.

Authors:  Nathalie Gault; Marina Esposito-Farèse; Matthieu Revest; Jocelyn Inamo; André Cabié; Élisabeth Polard; Jean-Sébastien Hulot; Jade Ghosn; Catherine Chirouze; Laurène Deconinck; Jean-Luc Diehl; Julien Poissy; Olivier Epaulard; Benjamin Lefèvre; Lionel Piroth; Etienne De Montmollin; Eric Oziol; Manuel Etienne; Cédric Laouénan; Patrick Rossignol; Dominique Costagliola; Emmanuelle Vidal-Petiot
Journal:  Fundam Clin Pharmacol       Date:  2021-05-16       Impact factor: 2.747

5.  Treatment with ACE inhibitors or ARBs and risk of severe/lethal COVID-19: a meta-analysis.

Authors:  Maria Elena Flacco; Cecilia Acuti Martellucci; Francesca Bravi; Giustino Parruti; Rosaria Cappadona; Alfonso Mascitelli; Roberto Manfredini; Lorenzo G Mantovani; Lamberto Manzoli
Journal:  Heart       Date:  2020-07-01       Impact factor: 5.994

Review 6.  SARS-CoV-2 pandemic and research gaps: Understanding SARS-CoV-2 interaction with the ACE2 receptor and implications for therapy.

Authors:  Prasun K Datta; Fengming Liu; Tracy Fischer; Jay Rappaport; Xuebin Qin
Journal:  Theranostics       Date:  2020-06-12       Impact factor: 11.556

7.  ACEI/ARB use and risk of infection or severity or mortality of COVID-19: A systematic review and meta-analysis.

Authors:  Xue Zhang; Jiong Yu; Li-Ya Pan; Hai-Yin Jiang
Journal:  Pharmacol Res       Date:  2020-05-15       Impact factor: 7.658

Review 8.  State-of-the-Art review: Hypertension practice guidelines in the era of COVID-19.

Authors:  Keith C Ferdinand; Thanh N Vo; Melvin R Echols
Journal:  Am J Prev Cardiol       Date:  2020-07-15

9.  Effects of underlying morbidities on the occurrence of deaths in COVID-19 patients: A systematic review and meta-analysis.

Authors:  Md Mostaured Ali Khan; Md Nuruzzaman Khan; Md Golam Mustagir; Juwel Rana; Md Saiful Islam; Md Iqbal Kabir
Journal:  J Glob Health       Date:  2020-12       Impact factor: 4.413

10.  Association of renin-angiotensin-aldosterone system inhibitors with mortality and testing positive of COVID-19: Meta-analysis.

Authors:  Yujiro Yokoyama; Tadao Aikawa; Hisato Takagi; Alexandros Briasoulis; Toshiki Kuno
Journal:  J Med Virol       Date:  2020-10-30       Impact factor: 20.693
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.